Clinical Microbiomics

GxP-aligned and GCP-supportive fecal sample microbiome sequencing for clinical trials, cohort studies, probiotic studies, and regulated microbiome research. 

Clinical microbiome sequencing for regulated studies

What is this service?

BaseClear provides clinical microbiome sequencing for regulated studies. The service can cover the full workflow from sample receipt and DNA extraction to high-throughput sequencing, quality control, reporting, and data delivery.

Who is it for?

This service supports clinical trial sponsors, CROs, microbiome companies, nutrition companies, research groups, and hospitals. It helps manage large sample volumes, batch consistency, traceability, documentation, multi-site collection, and reproducible sequencing for downstream clinical analysis.

Methodology

This service supports clinical trial sponsors, CROs, microbiome companies, nutrition companies, research groups, and hospitals. It helps manage large sample volumes, batch consistency, traceability, documentation, multi-site collection, and reproducible sequencing for downstream clinical analysis.

What you receive

Clients receive sequencing data, QC results, run metrics, technical reports, and secure data transfer. Documentation can be prepared in a GxP-aligned and GCP-supportive format with traceable sample handling, workflow records, and deviation reporting where needed.

How it works:

From Sample to Isolate

1

STEP 1

Study scoping

We review your study design, sample numbers, sequencing goals, controls, and reporting needs. BaseClear then defines the workflow, documentation level, data format, and project timeline.

2

STEP 2

Sample collection

Your team collects fecal samples using the agreed collection and stabilization format. BaseClear can advise on collection logistics, batch planning, and sample submission for multi-site clinical studies.

3

STEP 3

Sequencing workflow

BaseClear receives and tracks samples, then performs DNA extraction, QC, library preparation, and high-throughput Illumina sequencing. Controls can be included across extraction, library, and sequencing batches.

4

STEP 4

Report and data release

We compare treated and control cohorts using diversity, taxonomic, and microbiome stability metrics. Statistical analysis identifies significant differences and their biological relevance to treatment-related microbiome changes.

Discuss your Clinical Microbiome Study

Schedule a free consultation with our experts to discuss your testing needs and regulatory 
requirements. We’ll help design a compliant testing workflow for your project.

Proven expertise in microbial safety assessment

1000+

Sample clinical trial scale supported in project scoping

PE150

Illumina paired-end sequencing option for shotgun metagenomics

GxP

Controlled documentation and traceable workflow records

ISO/IEC 27001

Information security standard for data handling

Success Story:
How a clinical trial sponsor can structure large-scale fecal sample microbiome sequencing with BaseClear

Challenge

A clinical trial sponsor needed a scalable microbiome sequencing workflow for around 1,000 patients across the Nordics. The project required controlled sample handling, consistent DNA extraction, batch controls, documented QC, and secure data delivery suitable for clinical research.

Solution

BaseClear proposed a GxP-aligned and GCP-supportive workflow covering fecal sample collection, automated DNA extraction, QC, Illumina library preparation, NextSeq sequencing, whole-cell controls, technical reporting, and secure data delivery.

Result

The workflow gave a clear path from sample collection to reporting, with batch controls and documented QC. Optional add-ons include BioIT analysis, dPCR target quantification, and metabolomics.

Frequently Asked Questions

Which sample types can BaseClear process for clinical microbiome sequencing?

BaseClear can process fecal samples for clinical microbiome sequencing when the collection format, stabilization chemistry, and storage conditions are aligned before study start. Fecal samples can be collected using validated stabilization products, including Zymo Shield Fecal tubes where appropriate. Early alignment on collection logistics helps reduce site-to-site variability and supports consistent processing across large clinical studies.

BaseClear can provide GxP-aligned and GCP-supportive documentation for clinical microbiome sequencing studies. This includes traceable sample handling, documented QC steps, controlled workflow records, technical reporting, and secure data release. The exact documentation package should be agreed during project scoping so it matches the sponsor, CRO, or clinical study requirements.

Clinical microbiome studies can use shotgun metagenomic sequencing or targeted amplicon sequencing depending on the study question. Shotgun metagenomics is useful when the study needs species-level or functional insight, while targeted approaches such as 16S or ITS can support broader community profiling at lower complexity. BaseClear can align the sequencing strategy with sample number, required depth, budget, and downstream analysis plan.

Clinical microbiome sequencing projects can include whole-cell microbial controls, extraction controls, library preparation controls, sequencing controls, and negative controls. These controls help assess workflow performance, batch consistency, contamination risk, and sequencing quality. The control strategy should be defined before study start and kept consistent across batches.

The technical report can include DNA concentration, DNA quality, library concentration, fragment size, sequencing yield, Q30 scores, cluster density, lane balance, sample-level performance, control performance, and an overall run assessment. Deviation notes can be included where relevant. The report gives the clinical team a traceable technical record from sample processing to final data release.

BaseClear can provide BioIT analysis, dPCR assays, and metabolomics as add-on services for clinical microbiome projects. BioIT can include taxonomic profiling, functional profiling, diversity analysis, strain-level analysis, and custom reporting. dPCR can support targeted quantification or strain tracking, while metabolomics can support analysis of residual antibiotics, short-chain fatty acids, bile acids, and other relevant metabolites.

Ready to plan your clinical microbiome study?

Get your free consultation without commitment

Contact us